Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
MYGNShowing 0 of 3 quarters
Position history for BlackRock Finance, Inc.'s holdings in MYRIAD GENETICS INC
As of its last 13F, for Q2 2024, BlackRock Finance held 15,150,806 shares of MYGN (Myriad Genetics), worth $370.6M. It increased the position by 271,487 shares (+1.8%) from Q1 2024. BlackRock Finance held MYGN from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of MYGN: BlackRock, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC